Ilumya side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Ilumya. Common side effects include drug ineffective among females, and drug ineffective among males.
The phase IV clinical study is created by eHealthMe based on 780 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
780 people who take Ilumya and have side effects are studied.
What is Ilumya?
Ilumya has active ingredients of tildrakizumab-asmn. Currently, eHealthMe is studying from 784 Ilumya users.
Number of Ilumya reports submitted per year:
Ilumya side effects by time on the drug *:
Ilumya side effects by gender *:
Ilumya side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Ilumya?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on tildrakizumab-asmn (the active ingredients of Ilumya) and Ilumya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Ilumya:
- Ilumya (784 reports)
All Ilumya side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Flomax and Flatulence - 10 seconds ago
- Lyrica and Fluconazole drug interaction - 19 seconds ago
- Diphen and Inspra drug interaction - 36 seconds ago
- Vicodin and Nordette-21 drug interaction - 36 seconds ago
- Rifampin and Tapentadol drug interaction - 47 seconds ago
- Copaxone and Arthrotec drug interaction - a minute ago
- Depakote and Gocovri drug interaction - a minute ago
- Olmetec and Neulasta drug interaction - a minute ago
- Acyclovir and Flecainide Acetate drug interaction - a minute ago
- Triazolam and Zopiclone drug interaction - a minute ago